Title:
がんの処置のためのＨＰＫ１阻害剤としての２，３－ジヒドロ－１Ｈ－ピロロ［３，４－ｃ］ピリジン－１－オン誘導体
Document Type and Number:
Japanese Patent JP7118267
Kind Code:
B2
Abstract:
This invention relates to compounds of general Formula (I)and pharmaceutically acceptable salts thereof, in which R1, R1a, R2, R3, R4, and (R5)a are as defined herein, to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable salts thereof, and to methods of using such compounds, pharmaceutically acceptable salts and compositions for the treatment of abnormal cell growth, including cancer.
Inventors:
Rebecca Angaljego
Sajiv Krishnan Neil
Robert stephen cania
Omar Karido Ahmad
Ted William Johnson
Jamison Blythe Tuttle
Mean Jaraie
Michelle Ann McTigue
Dahui Joe
Matthew El Del Bell
Lou Joe
To Minjun
Anne-Marie Decart Schmidt
Sajiv Krishnan Neil
Robert stephen cania
Omar Karido Ahmad
Ted William Johnson
Jamison Blythe Tuttle
Mean Jaraie
Michelle Ann McTigue
Dahui Joe
Matthew El Del Bell
Lou Joe
To Minjun
Anne-Marie Decart Schmidt
Application Number:
JP2021525702A
Publication Date:
August 15, 2022
Filing Date:
November 12, 2019
Export Citation:
Assignee:
Pfizer Inc.
International Classes:
C07D471/04; A61K31/444; A61K31/5377; A61P35/00; C07D519/00
Foreign References:
| WO2018167147A1 | ||||
| WO2018049324A1 | ||||
| US20110230482 |
Attorney, Agent or Firm:
Nozomi Shimoto
Maki Sato
Miyuki Tatsuda
Ria Ikeda
Maki Sato
Miyuki Tatsuda
Ria Ikeda